V710 + Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Staphylococcal Infection
Conditions
Staphylococcal Infection
Trial Timeline
Mar 1, 2008 → Jun 1, 2008
NCT ID
NCT00735839About V710 + Placebo
V710 + Placebo is a phase 1 stage product being developed by Merck for Staphylococcal Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT00735839. Target conditions include Staphylococcal Infection.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00735839 | Phase 1 | Completed |
| NCT00518687 | Phase 2/3 | Terminated |
Competing Products
20 competing products in Staphylococcal Infection